HomeCompareBAYRY vs JEPQ

BAYRY vs JEPQ: Dividend Comparison 2026

BAYRY yields 0.26% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $25.1K in total portfolio value
10 years
BAYRY
BAYRY
● Live price
0.26%
Share price
$11.48
Annual div
$0.03
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.03
Full BAYRY calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — BAYRY vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAYRYJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAYRY + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAYRY pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAYRY
Annual income on $10K today (after 15% tax)
$22.21/yr
After 10yr DRIP, annual income (after tax)
$0.03/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, JEPQ beats the other by $1,829.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAYRY + JEPQ for your $10,000?

BAYRY: 50%JEPQ: 50%
100% JEPQ50/50100% BAYRY
Portfolio after 10yr
$32.3K
Annual income
$1,076.30/yr
Blended yield
3.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAYRY right now

BAYRY
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
0.9
Piotroski
5/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAYRY buys
0
JEPQ buys
0
No recent congressional trades found for BAYRY or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAYRYJEPQ
Forward yield0.26%11.10%
Annual dividend / share$0.03$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$19.7K$44.8K
Annual income after 10y$0.03$2,152.59
Total dividends collected$26.00$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: BAYRY vs JEPQ ($10,000, DRIP)

YearBAYRY PortfolioBAYRY Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$10,713$13.07$11,930$1,110.39$1.2KJEPQ
2$11,470$6.54$14,133$1,224.34$2.7KJEPQ
3$12,276$3.27$16,632$1,340.46$4.4KJEPQ
4$13,137$1.64$19,454$1,457.97$6.3KJEPQ
5$14,057$0.82$22,626$1,576.08$8.6KJEPQ
6$15,041$0.41$26,175$1,694.09$11.1KJEPQ
7$16,094$0.20$30,133$1,811.32$14.0KJEPQ
8$17,221$0.10$34,531$1,927.17$17.3KJEPQ
9$18,427$0.05$39,403$2,041.08$21.0KJEPQ
10$19,717$0.03$44,787$2,152.59$25.1KJEPQ

BAYRY vs JEPQ: Complete Analysis 2026

BAYRYStock

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Full BAYRY Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this BAYRY vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAYRY vs SCHDBAYRY vs JEPIBAYRY vs OBAYRY vs KOBAYRY vs MAINBAYRY vs XYLDBAYRY vs QYLDBAYRY vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.